FACULTY
DR TAKAHIRO TSUCHIKAWA
Director of Center for Neuroendocrine Neoplasms
Department of Gastroenterological Surgery II
Hokkaido University Hospital
Sapporo, Japan
Director of Center for Neuroendocrine Neoplasms
Department of Gastroenterological Surgery II
Hokkaido University Hospital
Sapporo, Japan
Education:
2004. Ph.D. (Dr. of Medical Science), Hokkaido University Graduate School of Medicine (Thesis: Hematopoietic Progenitor Cells as Possible Origins of Epithelial Thymoma in a Human T Lymphocyte Virus Type I pX Gene
Transgenic Rat Model)
1993 M.D., Kanazawa University School of Medicine
Professional Training and Employment
2015-present
Director of Center for Neuroendocrine Neoplasms, Hokkaido. University Hospital, Japan
Associate professor, Department of Gastroenterological Surgery II,
Hokkaido University Graduate School of Medicine, Japan
Research Interests
・Surgical strategy for pancreatic neuroendocrine neoplasms, especially for the organ preserving pancreatic surgery and extended hepatectomy for liver metastasis
・Multimodal treatment strategy for advanced neuroendocrine neoplasms
・Application of immunotherapy for hepato-biliary-pancreatic cancer utilizing cancer vaccine, CEA targeted CAR-T (Chimeric antigen receptor T) cells and Immune checkpoint inhibitor.
・Analyzing molecular mechanisms of immune recognition and escaping in tumor microenvironment of solid tumors.
BIBLIOGRAPHY (Selected recent publications for the first and second authorship)
1. Okawa Y, Tsuchikawa T, et al. Clinical Features of Pancreatic Neuroendocrine Microadenoma: A Single-Center Experience and Literature Review. Pancreas. 2022
2. Tsuchikawa T, et al. Clinical Impact of Organ-Preserving Surgery for Pancreatic Neuroendocrine Neoplasms: A Single Center Experience. Pancreas. 2021
3. Hane Y, Tsuchikawa T, et al . Immunological gene signature associated with the tumor microenvironment of pancreatic cancer following neoadjuvant chemotherapy. Pancreas. 2020
4. Kuwabara S, Tsuchikawa T, et al . Prognostic Relevance of Tertiary Lymphoid Organs Following NeoadjuvantChemoradiotherapy in Pancreatic Ductal Adenocarcinoma. Cancer Sci. 2019
2004. Ph.D. (Dr. of Medical Science), Hokkaido University Graduate School of Medicine (Thesis: Hematopoietic Progenitor Cells as Possible Origins of Epithelial Thymoma in a Human T Lymphocyte Virus Type I pX Gene
Transgenic Rat Model)
1993 M.D., Kanazawa University School of Medicine
Professional Training and Employment
2015-present
Director of Center for Neuroendocrine Neoplasms, Hokkaido. University Hospital, Japan
Associate professor, Department of Gastroenterological Surgery II,
Hokkaido University Graduate School of Medicine, Japan
Research Interests
・Surgical strategy for pancreatic neuroendocrine neoplasms, especially for the organ preserving pancreatic surgery and extended hepatectomy for liver metastasis
・Multimodal treatment strategy for advanced neuroendocrine neoplasms
・Application of immunotherapy for hepato-biliary-pancreatic cancer utilizing cancer vaccine, CEA targeted CAR-T (Chimeric antigen receptor T) cells and Immune checkpoint inhibitor.
・Analyzing molecular mechanisms of immune recognition and escaping in tumor microenvironment of solid tumors.
BIBLIOGRAPHY (Selected recent publications for the first and second authorship)
1. Okawa Y, Tsuchikawa T, et al. Clinical Features of Pancreatic Neuroendocrine Microadenoma: A Single-Center Experience and Literature Review. Pancreas. 2022
2. Tsuchikawa T, et al. Clinical Impact of Organ-Preserving Surgery for Pancreatic Neuroendocrine Neoplasms: A Single Center Experience. Pancreas. 2021
3. Hane Y, Tsuchikawa T, et al . Immunological gene signature associated with the tumor microenvironment of pancreatic cancer following neoadjuvant chemotherapy. Pancreas. 2020
4. Kuwabara S, Tsuchikawa T, et al . Prognostic Relevance of Tertiary Lymphoid Organs Following NeoadjuvantChemoradiotherapy in Pancreatic Ductal Adenocarcinoma. Cancer Sci. 2019